NewMediaWire distributes press releases on behalf of hundreds of publicly traded companies, as well as private corporations, non-profits and other public sector organizations. Founded and staffed by industry veterans, we offer a full complement of services including specialized delivery to financial sites and posting of photos and multimedia content. In addition, NewMediawire offers international and specialized services such as IR websites and industry specific distribution.
November 3, 2025 — Research Highlights: People with a condition in which protein build up stiffens heart walls – called transthyretin amyloid cardiomyopathy – were more likely to have a stroke if they also had a mechanical malfunction in the atrial chamber of their heart. A noninvasive risk assessment tool may help identify people with the condition who are at high stroke risk and might benefit from preventive measures, according to researchers.
November 3, 2025 — Research Highlights: Optimal cardiovascular health, based on the American Heart Association’s Life’s Essential 8 metrics, may decrease the risk of mild cognitive impairment and dementia for adults with Type 2 diabetes. Among adults with both Type 2 diabetes and a high genetic risk for dementia, researchers found that having moderate or high cardiovascular health, compared to having low cardiovascular health, greatly lowered the risk of developing mild cognitive impairment and dementia over 13 years.
November 3, 2025 — Research Highlights: A review of 5 years of health records for more than 130,000 adults with insomnia who had used melatonin for at least a year found they were more likely to be diagnosed with heart failure, require hospitalization for the condition or die from any cause. The association between melatonin and increased risk of heart failure or death found in this study, which cannot prove a cause-and-effect relationship, raises safety concerns about the use of melatonin, which is widely available, and may warrant more research on melatonin to assess its cardiovascular safety, researchers said.
November 3, 2025 — Research Highlights: For people with Type 2 diabetes, following at least six healthy lifestyle habits when taking GLP-1 RA medications can lower their risk of heart attack, stroke, hospital visits due to cardiovascular disease and death, more than medication alone or healthy lifestyle changes alone. A study of more than 63,000 military veterans with Type 2 diabetes who took GLP-1 RA medications found that those with at least six healthy lifestyle habits had a 50% lower risk of serious cardiovascular events when compared to veterans with a lower adherence to a healthy lifestyle who were receiving standard diabetes care but not taking GLP-1 RA medication.
November 3, 2025 — Research Highlights: Adults with Type 2 diabetes (T2D) and at moderate or high risk of cardiovascular disease who took low-dose aspirin were less likely to experience a serious cardiovascular event, including a heart attack, stroke or death, than peers who did not take aspirin. Any low-dose aspirin use was associated with significantly lower risk of having a heart attack or stroke compared to no low-dose aspirin use, with greater benefit observed among those individuals who took it the most often.
November 3, 2025 — Research Highlights: Adults with elevated levels of three biomarkers for heart disease—lipoprotein a (also called Lp(a)), remnant cholesterol and high-sensitivity C-reactive protein (hsCRP)—had nearly triple the risk of heart attack compared to those without elevated levels. In addition, people with elevated levels of only one of the three biomarkers had a 45% increased risk of heart attack and those with elevated levels of two biomarkers had double the risk.
November 3, 2025 — Research Highlights Higher levels of exposure to artificial light at night were linked to increased stress-related activity in the brain, inflamed arteries and a higher risk of heart disease, according to a small study of adults in Boston. Nighttime light pollution appeared to affect heart health, making it an environmental factor that could be changed to help reduce heart disease in communities with higher levels of nighttime light, researchers said.
November 3, 2025 — Research Highlights: An artificial intelligence (AI) tool detected structural heart problems using a single-lead ECG captured by the electrical heart sensor on the back and digital crown of a smartwatch. The AI algorithm was tested on single-lead ECGs taken on a smartwatch in a group of 600 adults.
November 3, 2025 — Multiple Strategic Capital Management Actions Boost Financial Strength, Reducing Leverage and Financing Costs HONG KONG - November 2, 2025 (NEWMEDIAWIRE) - FWD Group Holdings Limited (“FWD Group” or “FWD”) today announced strong new business growth for the nine months ended 30 September 2025[1]. New business sales were up 37 per cent to US$1.
October 31, 2025 — Global Brands Launch Innovative Products Survey Reveals AI, Smart City Development and Technological Advancement as Driving Forces in the Lighting Industry Two major lighting fairs and Eco Expo Asia have concluded with success, attracting some 62,000 buyers from 141 countries and regions The spotlight Hall of Connected Lighting featured some 70 top global brands. An AI smart lighting exhibitor at the Autumn Lighting Fair successfully confirmed an onsite order with a Thai buyer worth up to RMB8 million, double the value of their sales at the fair last year In an independent on-site survey, 61% of lighting industry respondents expect overall sales to grow in the next one to two years.
October 31, 2025 — Participation in FII Summit and business engagements to strengthen Hong Kong-Saudi economic cooperation HONG KONG - October 31, 2025 (NEWMEDIAWIRE) - A business delegation jointly organised by the Government of the Hong Kong Special Administrative Region (HKSAR) and the Hong Kong Trade Development Council (HKTDC) and led by Financial Secretary Paul Chan visited Riyadh, the capital of Saudi Arabia, from 27 to 31 October. The delegation attended the Future Investment Initiative (FII) Summit and met with senior government officials and business leaders to promote collaboration between Hong Kong and Saudi Arabia in areas, such as innovation and technology (I&T), smart city, AI, fintech and biotechnology, supporting the goals of Saudi Arabia’s Vision 2030.
October 31, 2025 — LOS ANGELES, CA - October 31, 2025 (NEWMEDIAWIRE) - D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, will release its financial results for the third quarter of fiscal year 2025 ended September 30, 2025 on Thursday, November 6 before market open.
October 31, 2025 — By Meg Flippin Benzinga DETROIT, MICHIGAN - October 31, 2025 (NEWMEDIAWIRE) - Chia-Lin Simmons, CEO of LogicMark Inc. (OTC: LGMK), was recently a guest on Benzinga’s All-Access.
October 31, 2025 — By Meg Flippin Benzinga DETROIT, MICHIGAN - October 31, 2025 (NEWMEDIAWIRE) - Securing aging loved ones takes more than cutting-edge, wearable devices. It requires state-of-the-art, artificial intelligence (AI)-driven software that can collect, read and analyze data from the devices in seconds.
October 31, 2025 — SAN DIEGO, CA - October 31, 2025 (NEWMEDIAWIRE) - Quantumzyme Corp. (OTCQB: QTZM), a biotechnology company pioneering enzyme engineering and green chemistry solutions, is pleased to announce details regarding the World Intellectual Property Organization (WIPO) publication of its international patent application titled “Modified Polypeptides for Enzymatic Synthesis of Ibuprofen” (Publication No.
October 31, 2025 — VANCOUVER, BC - October 31, 2025 (NEWMEDIAWIRE) - Critical Infrastructure Technologies Ltd. (CSE: CTTT) (OTC: CITLF) (FRA: X9V) (“CiTech” or the “Company”), a leading developer of autonomous, high-capacity mobile communications and security platforms, is pleased to announce that its ordinary shares have commenced trading on the OTCQB Venture Market in the United States under the symbol CITLF.
October 31, 2025 — DALLAS, TX - October 30, 2025 (NEWMEDIAWIRE) - Pulmonary embolism (PE), a type of blood clot in the lungs, sends more than half a million people to U. S.
October 31, 2025 — OncoX’s “Technology × Performance × Asset” Business Model Drives ABVC’s Licensing Portfolio Revaluation SILICON VALLEY, CA - October 31, 2025 (NEWMEDIAWIRE) - ABVC BioPharma, Inc. (NASDAQ: ABVC) today announced that its oncology partner OncoX BioPharma, Inc.
October 31, 2025 — Revolutionary AI SEO Software Recognized for Transforming Digital Marketing Landscape and Paving the Way for Agentic Marketing NEW YORK CITY - October 30, 2025 (NEWMEDIAWIRE) - Search Atlas Group has been awarded Best AI Search Software for OTTO SEO at the prestigious Global Search Awards, beating companies like Semrush and Ahrefs. Search Atlas’ victory comes from OTTO SEO’s ability to fully automate SEO execution, while Semrush’s AI Optimization (AIO) only provides recommendations, cementing Search Atlas’ position as a pioneer in AI-driven search optimization technology.
